Milk transfer and neonatal safety of tacrolimusFRENCH, Amy E; SOLDIN, Steven J; SOLDIN, Offie P et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 815-818, issn 1060-0280, 4 p.Article

A role for Schwann cells in the neuroregenerative effects of a non-immunosuppressive FK506 derivative, JNJ460BIRGE, R. B; WADSWORTH, S; PARRIS, K et al.Neuroscience. 2004, Vol 124, Num 2, pp 351-366, issn 0306-4522, 16 p.Article

Assessment of Nerve Regeneration Across Nerve Allografts Treated with TacrolimusHAN HAISHENG; ZUO SONGJIE; LI XIN et al.Artificial cells, blood substitutes, and biotechnology. 2008, Vol 36, Num 5, pp 465-474, 10 p.Article

TUMEFACTIVE DEMYELINATION, AN UNCOMMON FORM OF TACROLIMUS NEUROTOXICITYKIM, S. H; KIM, W; LEE, K. W et al.Neurology. 2011, Vol 76, Num 7, pp 672-674, issn 0028-3878, 3 p.Article

Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regenerationXIAOXIA LI; WEI WANG; GUOQIANG WEI et al.Biotechnology letters. 2010, Vol 32, Num 9, pp 1333-1337, issn 0141-5492, 5 p.Article

Tacrolimus leukoencephalopathy: A neuropathologic confirmationLAUIGNE, Catherine M; SHRIER, David A; KETKAR, Manoj et al.Neurology. 2004, Vol 63, Num 6, pp 1132-1133, issn 0028-3878, 2 p.Article

Mechanisms of the sensory effects of tacrolimus on the skinPEREIRA, U; BOULAIS, N; LEBONVALLET, N et al.British journal of dermatology (1951). 2010, Vol 163, Num 1, pp 70-77, issn 0007-0963, 8 p.Article

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipientsROY, Jean Nicholas; BARAMA, Azemi; POIRIER, Charles et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 9, pp 659-665, issn 1744-6872, 7 p.Article

Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label studyPONSETI, José M; AZEM, Jamal; FORT, José M et al.Clinical neurology and neurosurgery. 2005, Vol 107, Num 3, pp 187-190, issn 0303-8467, 4 p.Article

Bone marrow hypoplasia complicating tacrolimus (FK506) therapyNOSARI, Annamaria; MARBELLO, Laura; DE CARLIS, Luciano G et al.International journal of hematology. 2004, Vol 79, Num 2, pp 130-132, issn 0925-5710, 3 p.Article

Rapid inhibitory effect of Tacrolimus on T cell migration by suppressing CD29-related functionsMUNAKATA, Y; SAITO, T; WATANABE, T et al.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 2, pp 197-204, issn 0392-856X, 8 p.Article

Differential impact of the CYP3A5^*1 and CYP3A5^*3 alleles on pre-dose concentrations of two tacrolimus formulationsWEHLAND, Markus; BAUER, Steffen; BRAKEMEIER, Susanne et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 4, pp 179-184, issn 1744-6872, 6 p.Article

Isolation and Identification of a Novel Microorganism Producing the Immunosuppressant TacrolimusHYUNG SOO KIM; YOUNG IN PARK.Journal of bioscience and bioengineering. 2008, Vol 105, Num 4, pp 418-421, issn 1389-1723, 4 p.Article

Topical tacrolimus has a limited direct effect on ultraviolet B-irradiated keratinocytes: implications for its photocarcinogenic potentialLAN, C.-C. E; YU, H.-S; HUANG, S.-M et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 173-179, issn 0307-6938, 7 p.Article

Bioequivalence of a new strength tacrolimus capsule under developmentBEKERSKY, I; DRESSLER, D; BOSWELL, G. W et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1457-1459, issn 0041-1345Conference Paper

Renal histology with varying FK506 blood levelsGABER, L. W; MOORE, L. W; REED, L et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 186Conference Paper

Roles of fkbN in Positive Regulation and tcs7 in Negative Regulation of FK506 Biosynthesis in Streptomyces sp. Strain KCTC 11604BPMO, Sangjoon; YOUNG JI YOO; YEON HEE BAN et al.Applied and environmental microbiology (Print). 2012, Vol 78, Num 7, pp 2249-2255, issn 0099-2240, 7 p.Article

Validation of a liquid chromatographic method for determination of tacrolimus in pharmaceutical dosage formsMOYANO, Maria A; SIMIONATO, Laura D; PIZZORNO, Maria T et al.Journal of AOAC International. 2006, Vol 89, Num 6, pp 1547-1551, issn 1060-3271, 5 p.Article

Tacrolimus (FK 506) overdose : A report of five casesMRVOS, R; HODGMAN, M; KRENZELOK, E. P et al.Journal of toxicology. Clinical toxicology. 1997, Vol 35, Num 4, pp 395-399, issn 0731-3810Article

Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicityVENNETI, Sriram; MOSS, Heather E; LEVIN, Marc H et al.Journal of the neurological sciences. 2011, Vol 301, Num 1-2, pp 112-115, issn 0022-510X, 4 p.Article

Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesisSALEHI-NAJAFABADI, Zahra; BARREIRO, Carlos; MARTINEZ-CASTRO, Miriam et al.Applied microbiology and biotechnology. 2011, Vol 92, Num 5, pp 971-984, issn 0175-7598, 14 p.Article

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantationGOTO, Maki; MASUDA, Satohiro; KIUCHI, Tetsuya et al.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 471-478, issn 0960-314X, 8 p.Article

Reversibility of Cytotoxic Edema in Tacrolimus LeukoencephalopathyYILMAZ, Sanem; GOKBEN, Sarenur; ARIKAN, Cigdem et al.Pediatric neurology. 2010, Vol 43, Num 5, pp 359-362, issn 0887-8994, 4 p.Article

Calcineurin-inhibitor induced pain syndrome (CIPS) : a severe disabling complication after organ transplantationGROTZ, Wolfgang H; BREITENFELDT, Marie K; BRAUNE, Stefan W et al.Transplant international. 2001, Vol 14, Num 1, pp 16-23, issn 0934-0874Article

Effects of tacrolimus on an organotypic raft-culture model mimicking oral mucosaRAUTAVA, J; PÖLLÄNEN, M; LAINE, M. A et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 8, pp 897-903, issn 0307-6938, 7 p.Article